GLPwatch

Adlyxin vs Soliqua

Drug comparison

Last updated 2026-05-28 15:46 UTC

Adlyxin and Soliqua are both injectable medications for type 2 diabetes made by Sanofi, and both contain the active ingredient lixisenatide. The main difference is that Adlyxin is a standalone drug, while Soliqua combines lixisenatide with another diabetes medication called insulin glargine in a single injection.

AI summary of the sources below.

Adlyxin Soliqua
Active ingredientlixisenatidelixisenatide
Manufacturersanofisanofi
Routesubcutaneous injectionsubcutaneous injection
FDA-approved fortype 2 diabetestype 2 diabetes
Label updated2026-03-18

Compare full details on the Adlyxin and Soliqua pages.